참고문헌
- Lusis AJ. Atherosclerosis. Nature 2000;407:233-41. https://doi.org/10.1038/35025203
- Noh HJ, Kwon NH, Joo SB. Severity of coronary atherosclerosis: influence of metabolic syndrome risk factor clustering and hs-CRP. Korean Circ J 2006;36:802-8. https://doi.org/10.4070/kcj.2006.36.12.802
- Rattazi M, Faggin E, Bertipaglia B, Pauletto P. Innate immunity and atherogenesis. Lupus 2005;14:747-51. https://doi.org/10.1191/0961203305lu2213oa
- Hansson GK, Robertson AL, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006;1:297-329. https://doi.org/10.1146/annurev.pathol.1.110304.100100
- Koo BK, Choi DH, Ryu SK, et al. Role of inflammation on coronary artery disease in Koreans. Korean Circ J 2002;32:988-95.
- Kim TI, Chae SC, Yang DH, Shin SC, et al. Short-term prognostic value of CRP in the patients with acute coronary syndrome. Korean Circ J 2000;30:1387-94.
- Mantovani A, Garlanda C, Bottazzi B. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 2003;21(Suppl 2):S43-7. https://doi.org/10.1016/S0264-410X(03)00199-3
- Mantovani A, Garlanda C, Bottazzi B, et al. The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol 2006;45:326-30. https://doi.org/10.1016/j.vph.2006.08.011
- Napoleone E, Di Santo A, Bastone A, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 2002;22:782-7. https://doi.org/10.1161/01.ATV.0000012282.39306.64
- Peri G, Introna M, Corradi D, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000;102:636-41. https://doi.org/10.1161/01.CIR.102.6.636
- Suzuki S, Takeishi Y, Niizeki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 2008;155:75-81. https://doi.org/10.1016/j.ahj.2007.08.013
- Moon DK, Lee DH, Youn HJ, et al. Pentraxin 3 as an inflammatory marker in subjects with metabolic syndrome. Korean J Med 2007;451S. Abstract.
- Alberti L, Gilardini L, Zulian A, et al. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis 2009;202:455-60. https://doi.org/10.1016/j.atherosclerosis.2008.05.015
- Kim JA, Choi CJ, Yum KS. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 2006;21:1048-53. https://doi.org/10.3346/jkms.2006.21.6.1048
- Zenetti M, Bosutti A, Ferreira C, et al. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med 2009;9:243-8. https://doi.org/10.1007/s10238-009-0039-z
- Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004;110:2349-54. https://doi.org/10.1161/01.CIR.0000145167.30987.2E
- Introna M, Alles VV, Castellano M, et al. Cloning of mouse PTX3, a new marker of the pentraxin gene family expressed at extrahepatic sites. Blood 1996;87:1862-72.
- Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007;11:723-38. https://doi.org/10.1111/j.1582-4934.2007.00061.x
- Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83. https://doi.org/10.1038/nri1937
- Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarctionpotential association with C-reactive protein. Circ J 2008;72:415-9. https://doi.org/10.1253/circj.72.415
- Clavijo LC, Pinto TL, Kuchulakanti PK, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Rrevasc Med 2006;7:7-11. https://doi.org/10.1016/j.carrev.2005.10.007
- Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-9. https://doi.org/10.1016/S0140-6736(05)67663-5
- Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women. Circulation 2004;109:706-13. https://doi.org/10.1161/01.CIR.0000115514.44135.A8
피인용 문헌
- Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease vol.6, pp.12, 2010, https://doi.org/10.2215/cjn.02320311
- Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity vol.301, pp.6, 2011, https://doi.org/10.1152/ajpendo.00163.2011
- Effects of Ecklonia cava Polyphenol in Individuals with Hypercholesterolemia: A Pilot Study vol.15, pp.11, 2012, https://doi.org/10.1089/jmf.2011.1996
- Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps vol.3, pp.None, 2012, https://doi.org/10.3389/fimmu.2012.00378